Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2018
- Klassifikation
-
Medizin, Gesundheit
- Schlagwort
-
Liver--Cancer
Therapeutics
Inhibition
Cancer
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2018
- Urheber
-
Ardelt, Maximilian
- Beteiligte Personen und Organisationen
-
Vollmar, Angelika
- URN
-
urn:nbn:de:bvb:19-226824
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ardelt, Maximilian
- Vollmar, Angelika
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2018
Ähnliche Objekte (12)
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma
CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment
Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids
Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma
CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment
Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids
Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy
Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma
CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
Sorafenib inhibits interferon production by plasmacytoid dendritic cells in hepatocellular carcinoma
Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment
Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids